Alcon Inc. remains a global leader in eye care, benefiting from aging demographics and technological innovation. Learn more ...

Looking ahead to 2026, Stonesifer noted anticipated tailwinds from continued product launches and incremental tariff headwinds of $50 million to $100 million versus 2025, with R&D expected toward the ...

The global eyecare company, with manufacturing and research facilities in Berks County, reduced its full-year projections in ...

STAAR shareholders are set to vote on the proposed Alcon merger on December 19, following a go-shop period that allows the ...

Global Intraocular Lens Market OverviewThe Global Intraocular Lens Market, valued at approximately US $3.9 billion in 2021, ...

Alcon Inc. recently reported its third quarter and nine-month earnings for the period ended September 30, 2025, showing year-over-year growth in sales and revenue, while net income for the quarter ...

Alcon Delivers Solid Third-Quarter 2025 Results with Accelerated Growth in Equipment and Ocular Health; Unity VCS Momentum ...

Alcon Inc (ALC) reports a 5% increase in revenue, driven by robust performance in surgical and ocular health segments, despite facing margin challenges and tariff-related costs.

Investing.com -- The controversial merger between STAAR Surgical Company (NASDAQ:STAA) and Alcon AG (NYSE:ALC) is taking on a ...

Although the revenue and EPS for Alcon (ALC) give a sense of how its business performed in the quarter ended September 2025, ...

Jana announced a top portfolio position in Cooper and plans to push for strategic alternatives, including a potential ...

STAAR Surgical ’s (NASDAQ:STAA) largest shareholder is intensifying calls for board changes after the implantable lens maker agreed last week to revise its merger agreement with Alcon AG (NYSE:ALC) ...